N. Arrighetti

发表

Anionic glycolipids related to glucuronosyldiacylglycerol inhibit protein kinase Akt.

P. Perego, D. Colombo, F. Compostella, 2015, Organic & biomolecular chemistry.

Endosomal Escape of Polymer-Coated Silica Nanoparticles in Endothelial Cells.

Brandon S. Brown, A. De Vita, I. K. Yazdi, 2020, Small.

Improved Apoptotic Cell Death in Drug-Resistant Non–Small-Cell Lung Cancer Cells by Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Based Treatment

N. Zaffaroni, F. Zunino, P. Perego, 2014, The Journal of Pharmacology and Experimental Therapeutics.

Improved apoptotic cell death in drug-resistant non small cell lung cancer cells by TRAIL-based treatment

N. Zaffaroni, F. Zunino, P. Perego, 2013 .

PKC-alpha modulation by miR-483-3p in platinum-resistant ovarian carcinoma cells.

L. De Cecco, N. Zaffaroni, P. Perego, 2016, Toxicology and applied pharmacology.

A trifunctional self-immolative spacer enables drug release with two non-sequential enzymatic cleavages.

L. Belvisi, P. Perego, N. Arrighetti, 2021, Chemical communications.

Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery.

Roberto Molinaro, Manuela Sushnitha, Ennio Tasciotti, 2017, Biomaterials.

Amniotic fluid allograft enhances the host response to ventral hernia repair using acellular dermal matrix

Joseph S. Fernandez-Moure, E. Tasciotti, J. Fernandez-Moure, 2021, Journal of tissue engineering and regenerative medicine.

Overcoming clinical resistance to EZH2 inhibition using 1 rational epigenetic combination therapy 2

E. Stanchina, A. Kentsis, M. Gounder, 2023 .

Synergistic Interaction of Histone Deacetylase 6- and MEK-Inhibitors in Castration-Resistant Prostate Cancer Cells

N. Zaffaroni, P. Perego, N. Carenini, 2020, Frontiers in Cell and Developmental Biology.

RNA Interference Approaches and Assessment of New Delivery Systems to Target Heparanase in Soft-tissue Sarcomas

N. Arrighetti, 2019 .

Antitumor activity of a novel homodimeric SMAC mimetic in ovarian carcinoma.

F. Vasile, D. Potenza, L. Belvisi, 2014, Molecular pharmaceutics.

Axl molecular targeting counteracts aggressiveness but not platinum‐resistance of ovarian carcinoma cells

N. Zaffaroni, C. Lanzi, P. Perego, 2017, Biochemical pharmacology.

miR-875-5p counteracts epithelial-to-mesenchymal transition and enhances radiation response in prostate cancer through repression of the EGFR-ZEB1 axis.

Claudio Stucchi, Tiziana Rancati, M. Dugo, 2017, Cancer letters.

Recent Progresses in Conjugation with Bioactive Ligands to Improve the Anticancer Activity of Platinum Compounds.

P. Perego, D. Colombo, N. Arrighetti, 2021, Current medicinal chemistry.

Differential outcome of MEK 1 / 2 inhibitor-platinum combinations in platinum-sensitive and-resistant ovarian carcinoma cells

N. Zaffaroni, F. Zunino, C. Lanzi, 2014 .

miRNAs as Therapeutic Tools and Biomarkers for Prostate Cancer

N. Arrighetti, G. Beretta, 2021, Pharmaceutics.

Overactive IGF1/Insulin Receptors and NRASQ61R Mutation Drive Mechanisms of Resistance to Pazopanib and Define Rational Combination Strategies to Treat Synovial Sarcoma

N. Zaffaroni, E. Favini, C. Lanzi, 2019, Cancers.

Upregulation of ERK-EGR1-heparanase axis by HDAC inhibitors provides targets for rational therapeutic intervention in synovial sarcoma

N. Zaffaroni, E. Favini, C. Lanzi, 2021, Journal of Experimental & Clinical Cancer Research.

Differential outcome of MEK1/2 inhibitor-platinum combinations in platinum-sensitive and -resistant ovarian carcinoma cells.

N. Zaffaroni, F. Zunino, C. Lanzi, 2014, Cancer letters.

Exosome-like nanovectors for drug delivery in cancer.

E. Tasciotti, M. Evangelopoulos, N. Arrighetti, 2019, Current medicinal chemistry.

Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals

N. Zaffaroni, P. Perego, N. Carenini, 2014, Oncotarget.

Phosphatidylinositol 3‐Phosphate Mimics Based on a Sulfoquinovose Scaffold: Synthesis and Evaluation as Protein Kinase B Inhibitors

F. Nicotra, P. Perego, D. Colombo, 2014 .

Leukocyte-mimicking nanovesicles for effective doxorubicin delivery to treat breast cancer and melanoma.

Nupur Basu, A. De Vita, Assaf Zinger, 2019, Biomaterials science.

The deubiquitinase USP8 regulates ovarian cancer cell response to cisplatin by suppressing apoptosis

P. Perego, N. Carenini, S. Linder, 2022, Frontiers in Cell and Developmental Biology.

Caffeic acid phenethyl ester targets ubiquitin-specific protease 8 and synergizes with cisplatin in endometrioid ovarian carcinoma cells.

P. Perego, N. Carenini, S. Linder, 2022, Biochemical pharmacology.

Drug Combinations with HDAC Inhibitors in Antitumor Therapy.

N. Arrighetti, C. Corno, L. Gatti, 2015, Critical reviews in oncogenesis.

Targeting EZH2 in SMARCB1-deficient sarcomas: advances and opportunities to potentiate the efficacy of EZH2 inhibitors.

C. Lanzi, G. Cassinelli, N. Arrighetti, 2023, Biochemical pharmacology.

Overcoming clinical resistance to EZH2 inhibition using rational epigenetic combination therapy.

M. Ladanyi, R. Somwar, A. Kentsis, 2024, Cancer discovery.